This week in Other Barks & Bites: the Federal Circuit revives patent infringement claims asserted against Facebook’s News Feed; the CAFC also remanded a trio of cases to the USPTO to cure constitutional issues the court found in Arthrex; the USPTO announces new members of the PPAC and TPAC public advisory committees; the Copyright Royalty Board announces its intent to audit several companies for royalty payments under statutory licenses; Juno Therapeutics seeks enhanced damages of $1.5 billion for Kite Pharma’s willful infringement; HTC patent win in China includes damages award that greatly exceeds the statutory maximum; and the EU Court of Justice finds that a GlaxoSmithKline patent deal with generic drugmakers may have violated EU competition law.
Patent
- Enablement
- Fee Shifting
- Litigation
- Senate Judiciary Committee Advances Legislation to Reduce Drug Prices, Rein in Pharma Industry Practices
- Federal Circuit Nixes Appeal on Claims of Unfair Treatment by California Court in Pro Se Lawsuit Over Restrictions to Cancer Research
- The Washington Football Team’s Trademark Journey: Over the Bumps and Full Speed Ahead
- This Week in Washington IP: Energizing Technology Transfer, Case Studies in International Offshore Wind Innovation and Celebrating 75 Years of the Lanham Act
- ‘AISITAs’ and Written Description Requirements: Considerations and Guidance for AI Patent Applications
Recent Posts
- Senate Judiciary Committee Advances Legislation to Reduce Drug Prices, Rein in Pharma Industry Practices
- Federal Circuit Nixes Appeal on Claims of Unfair Treatment by California Court in Pro Se Lawsuit Over Restrictions to Cancer Research
- The Washington Football Team’s Trademark Journey: Over the Bumps and Full Speed Ahead
- This Week in Washington IP: Energizing Technology Transfer, Case Studies in International Offshore Wind Innovation and Celebrating 75 Years of the Lanham Act
- ‘AISITAs’ and Written Description Requirements: Considerations and Guidance for AI Patent Applications